Explore Our Biomarker Menu

Biomarker:

Chk1 (pS296)

Biological or Clinical Significance:

Chk1 is a serine/threonine-protein kinase involved in cell cycle arrest when DNA damage has occurred, and it plays an important role in DNA damage checkpoint, embryonic development and tumor suppression. Chk1 is activated in response to replication blocks and genotoxic stress, via phosphorylation of serines 317 and 345. Activated Chk1 can inactivate cdc25c through phosphorylation at Serine 216. Phosphorylation of cdc25c prevents activation of the CDC2-cyclin B complex and prevents entry into M-phase.

References:

Analyte:

Chk1 (pS296)

Matrix:

Status:

Experienced Running

Sensitivity-LLOQ:

Sensitivity-ULOQ:

platform

MSD-ECL

Required Sample Volume

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.


    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.